Table 1.

Description of the study population who received a 1st, 2nd or 3rd treatment (TX)

	1st TX	2nd TX	3rd TX
	N = 2835 (%)	N = 1226 (%)	N = 551 (%)
Age at start of treatment
< 60	48	51	51
60–70	30	34	32
> 71	18	13	14
Average (years)	59.5	58.8	59.1
Median (years)	59.1	58.1	58.4
Hormonal status
HR+	65	62	59
HR−	35	38	41

HR+ hormone-positive tumour, HR− hormone-negative tumour